Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137643 · ClinicalTrials.gov registry record
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A clinical trial of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT01137643: Recruiting study of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01137643 is a study of Lymphoma and Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 15,000 participants, above the 434-participant average among 299 other Lymphoma trials with a reported enrollment target (3356% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01137643, a study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER cytology specimen collection procedure
Study Locations (1)
North Carolina
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2009-07 |
| Est. Completion | 2040-07 |
What NCT01137643 shows while recruiting
NCT01137643 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 434-participant average among 299 other Lymphoma trials with a reported enrollment target (3356% higher).
The record links to 8 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which biologic sample preservation procedure is the first listed.
NCT01137643 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01137643 about?
NCT01137643 is a clinical study titled "Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer". RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic c...
What is the current status of trial NCT01137643?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2009-07. Estimated completion is 2040-07.
What conditions does trial NCT01137643 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Plasma Cell Neoplasm, Chronic Myeloproliferative Disorders.
What interventions are being tested in trial NCT01137643?
The interventions under investigation include: biologic sample preservation procedure (OTHER), cytology specimen collection procedure (OTHER).
Who is sponsoring clinical trial NCT01137643?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01137643 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01137643's enrollment target sits among peer trials
15,000 2nd of 299 the highest of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- NCT03050762 · 15,000 participants
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia